Sugi Predict

Sugi Predict / Compounds / SCHEMBL697900

SCHEMBL697900

SCHEMBL697900

O=CNC(Cc1ccccc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.61
▸ MEN1 O00255 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ TAAR1 Q96RJ0 1/20 0.58
▸ MME P08473 3/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.53
▸ ACE P12821 2/20 0.53
▸ CYP1A2 P05177 1/20 0.52
▸ NAALAD2 Q9Y3Q0 2/20 0.51
▸ MMP2 P08253 4/20 0.50
▸ MMP9 P14780 3/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ FOLH1 Q04609 1/20 0.50
▸ ADAMTS4 O75173 1/20 0.50
▸ CPA1 P15085 1/20 0.49
▸ ACE2 Q9BYF1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL27636787 1.00 EPHX1 (0.61) EPHX1MEN1KMT2ATAAR1MME
SCHEMBL697901 1.00 EPHX1 (0.61) EPHX1MEN1KMT2ATAAR1MME
SCHEMBL8211678 1.00 EPHX1 (0.61) EPHX1MEN1KMT2ATAAR1MME
SCHEMBL28267264 0.98 EPHX1 (0.59) EPHX1MEN1KMT2ATAAR1MME
SCHEMBL27785417 0.98 EPHX1 (0.59) EPHX1MEN1KMT2ATAAR1MME
SCHEMBL10494133 0.98 EPHX1 (0.59) EPHX1MEN1KMT2ATAAR1MME
SCHEMBL10494141 0.98 EPHX1 (0.59) EPHX1MEN1KMT2ATAAR1MME
SCHEMBL28267266 0.98 EPHX1 (0.59) EPHX1MEN1KMT2ATAAR1MME
Pyrazine SCHEMBL27888355 0.92 EPHX1 (0.53) EPHX1MEN1KMT2ATAAR1MME
Pyrazine SCHEMBL27888356 0.92 EPHX1 (0.53) EPHX1MEN1KMT2ATAAR1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12292445-B2 Methods of selecting subjects for treatment with metabolomic modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-05-06 — — US claimed
US-20210364526-A1 METHODS OF SELECTING SUBJECTS FOR TREATMENT WITH METABOLOMIC MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-11-25 — — US claimed
US-20190310269-A1 SYSTEMS AND METHODS FOR MEASURING OBESITY USING METABOLOME ANALYSIS HUMAN LONGEVITY, INC. 2019-10-10 — — US claimed
US-20140127144-A1 Flavour Modifying Compounds GIVAUDAN S. A. (CH) 2014-05-08 — — US claimed
EP-1593674-B1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2011-07-20 — — EP claimed
US-20060149077-A1 Optically active bisoxazoline compounds, process for production of the same and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-06 — — US claimed
EP-1593674-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-11-09 — — EP claimed
EP-1081149-B1 PYRAZOLO 1,5-a]PYRIMIDINE DERIVATIVES OTSUKA PHARMA CO LTD (JP) 2003-04-02 — — EP claimed
US-6372749-B1 PHARMACOLOGICAL EFFECTS SUCH AS ANALGESIC ACTION, INHIBITORY EFFECT ON NITROGEN MONOXIDE SYNTHETASE AND THE LIKE AND ARE USEFUL AS ANALGESICS. OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2002-04-16 — — US claimed
EP-1081149-A1 PYRAZOLO 1,5-a]PYRIMIDINE DERIVATIVES OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2001-03-07 — — EP claimed
US-4749691-A Peptide, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-07 — — US claimed
US-4725582-A IMMUNE RESPONSE ENHANCERS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1988-02-16 — — US claimed
JP-2306942-A — — None — — JP disclosed
JP-62114970-A — — None — — JP disclosed
US-20260076944-A1 COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH UNIV CALIFORNIA (US) 2026-03-19 — — US disclosed
US-20250375505-A1 COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM UNIV CALIFORNIA (US) 2025-12-11 — — US disclosed
EP-0174358-A1 NOVEL DIASTEREOMER SALTS OF PHENYLALANINE AND N-ACYL DERIVATIVES THEREOF AND PROCESS FOR THE SEPARATION OF OPTICALLY ACTIVE PHENYLALANINE AND N-ACYL DERIVATIVES THEREOF ALKALOIDA VEGYéSZETI GYáR (HU) 1986-03-19 — — EP disclosed
WO-1985003932-A1 NOVEL DIASTEREOMER SALTS OF PHENYLALANINE AND N-ACYL DERIVATIVES THEREOF AND PROCESS FOR THE SEPARATION OF OPTICALLY ACTIVE PHENYLALANINE AND N-ACYL DERIVATIVES THEREOF ALKALOIDA VEGYÉSZETI GYÁR (HU) 1985-09-12 — — WO disclosed
US-4262092-A Process for producing N-acyl-D-phenylalanine ester ETHYL CORPORATION (US) 1981-04-14 — — US disclosed
US-4151198-A Resolution of N-acyl-DL (+)-phenylalanines AMERICAN CYANAMID COMPANY (US) 1979-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060149077-A1 Optically active bisoxazoline compounds, process for production of the same and use thereof ACSL3, ADSL, SQLE EPHX1 512/4885MEN1 3119/4885KMT2A 4666/4885
US-20140127144-A1 Flavour Modifying Compounds TAS2R1, TAS1R2, TAS2R5 EPHX1 3770/4885MEN1 982/4885KMT2A 1026/4885
US-20250375505-A1 COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM CYP27A1, LIPC, CYP46A1 EPHX1 716/4885MEN1 2550/4885KMT2A 3068/4885
US-20260076944-A1 COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH IDO1, INMT, IDO2 EPHX1 3231/4885MEN1 4680/4885KMT2A 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.